Amivas' Artesunate Gets FDA Approval As Only Drug In US To Treat Severe Malaria

The U.S. Food and Drug Administration granted approval for Artesunate for Injection 110 mg, powder and solvent for solution to biopharmaceutical company Amivas (US), LLC as the only FDA-approved drug now in the U.S. for the first-line treatment of severe malaria in adult and pediatric patients. It is also the first FDA-approved product that Amivas has introduced to their commercial portfolio.

from RTT - Biotech https://ift.tt/2AcBtUk
via IFTTT